Mark James Daniel
CIK: 0002092593
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOS
ATOSSA THERAPEUTICS, INC.
Officer
Discretionary Trading P&L
Holdings
About Daniel Mark James
Daniel Mark James (SEC CIK 0002092593) files insider reports with the SEC as Chief Financial Officer of ATOSSA THERAPEUTICS, INC. (ATOS).
Signal8 holds 3 ownership filings by Daniel Mark James (1 Form 3, 2 Form 4), filed between Oct 21, 2025 and Mar 30, 2026. Those filings report 2 transactions, from Oct 14, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Daniel Mark James's filings is in SEATTLE, WA.
Recent filings by Daniel Mark James
Other insiders filing for ATOSSA THERAPEUTICS, INC. (ATOS)
- Steinhart Richard I, Director
- Chen Shu-Chih, Director
- Remmel H. Lawrence, Director
- Finn Jonathan, Director
- Galli Stephen J, Director
- Cigler Tessa, Director